In vivo studies demonstrate that endothelin-1 traps are a potential therapy for type I diabetes
ConclusionData from this study show that in a mouse model ET-traps have a potent and significant therapeutic effect on diabetes disease pathology. Future studies could further evaluate the use of ET-traps as a therapy for diabetes, including taking them through clinical trials.
Source: Journal of Diabetes and Metabolic Disorders - Category: Endocrinology Source Type: research
More News: Cardiology | Cardiomyopathy | Clinical Trials | Diabetes | Diabetes Type 1 | Endocrinology | Heart | Insulin | Pathology | Study | Urology & Nephrology